<?xml version="1.0" encoding="UTF-8"?>
<p>A surge in funding for MDT rollout, shortened treatment regimens, and changing case definitions of leprosy led to a considerable decrease in recorded leprosy prevalence by the end of the 1980s [
 <xref rid="pmed.1002735.ref046" ref-type="bibr">46</xref>]. Amid global progress and optimism, the WHA passed a resolution in 1991 seeking to ‘eliminate leprosy as a public health problem by 2000’, defining elimination as reduction of prevalence to less than 1 in 10,000 globally. The 1/10,000 target was chosen arbitrarily, with limited consultation [
 <xref rid="pmed.1002735.ref047" ref-type="bibr">47</xref>]; it was thought that attaining this prevalence would eventually interrupt leprosy transmission, but it was not supported by evidence (e.g., from modelling) [
 <xref rid="pmed.1002735.ref048" ref-type="bibr">48</xref>].
</p>
